Advisory Services Network’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Advisory Services Network’s Portfolio LOGC Stock Details LOGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-84	Closed	–	–	3543
2021 Q2	$0	Buy	+84	New	+$427	﹤0.01%	3682
2021 Q1	–	Sell	-84	Closed	-$1K	–	3204
2020 Q4	$1K	Sell	84 -500	-86%	-$3.35K	﹤0.01%	3236
2020 Q3	$5K	Buy	+584	New	+$4.43K	﹤0.01%	2809

Other funds holding LOGC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Advisory Services Network's LOGC Position: Q3 2021 in Review

Advisory Services Network sold out of LogicBio Therapeutics, Inc. Common Stock (LOGC) in Q3 2021, closing a stake of 84 shares.

Advisory Services Network first reported a position in LOGC in Q3 2020 and held it in 3 quarters. The position peaked at $5K in Q3 2020. 57 funds tracked by Wall St. Rank hold LOGC as of Q3 2021.

Advisory Services Network reported no remaining LogicBio Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 84 LogicBio Therapeutics, Inc. Common Stock shares in Q3 2021.
Advisory Services Network first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Advisory Services Network's LogicBio Therapeutics, Inc. Common Stock position peaked at $5K in Q3 2020.
57 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.